A5065564779- Viral-associated cancers and disorders
- Inflammatory Bowel Disease
- RNA modifications and cancer
- Cancer-related molecular mechanisms research
- Hepatitis B Virus Studies
- Rabies epidemiology and control
- Parvovirus B19 Infection Studies
- Clinical Nutrition and Gastroenterology
- Cancer Diagnosis and Treatment
- Musculoskeletal pain and rehabilitation
- Virology and Viral Diseases
- Musculoskeletal Disorders and Rehabilitation
- Cancer Genomics and Diagnostics
- Salivary Gland Tumors Diagnosis and Treatment
- Endometriosis Research and Treatment
- Head and Neck Cancer Studies
- Lung Cancer Treatments and Mutations
- Medical Imaging and Pathology Studies
- Immunotherapy and Immune Responses
- Polyomavirus and related diseases
- Cytomegalovirus and herpesvirus research
- Endometrial and Cervical Cancer Treatments
- Monoclonal and Polyclonal Antibodies Research
- Anorectal Disease Treatments and Outcomes
- Tea Polyphenols and Effects
Guangxi Medical University
2025
Stomatology Hospital
2025
University of California, Los Angeles
2025
Washington University in St. Louis
2024-2025
Beijing Chao-Yang Hospital
2025
Capital Medical University
2025
Fudan University Shanghai Cancer Center
2024
Shanghai Medical College of Fudan University
2024
Viva Biotech (China)
2016
A nasopharyngeal carcinoma (NPC) mass screening trial using a combination of immunoglobulin antibodies to Epstein-Barr virus capsid antigen and nuclear antigen-1 by enzyme-linked immunosorbent assay in addition indirect mirror examination the nasopharynx and/or lymphatic palpation (IMLP) was conducted southern China. Cantonese aged 30–59 years residing 2 cities randomly selected cluster sampling, Sihui Zhongshan, were invited participate this from May 2008 through 2010. Participants offered...
Abstract Background The interleukin (IL)-23 signaling is a vital pathway in Crohn’s disease (CD). IL-23 activates T-helper (Th) 17 cells, IL-17-secreting CD8 T (Tc)17 γδ natural killer (NK) and group 3 innate lymphoid cells (ILC3) to secrete inflammatory cytokines including IL-17, IFN-γ, TNF-α. Risankizumab the first selective antagonist approved for moderate-to-severe CD; however, no biomarker currently exists predict response this medication. Here, we characterized phenotypes of...
As an indolent malignant tumor, the long-term management of low-grade endometrial stromal sarcoma (LGESS) patients required awareness, especially recurrences. Unfortunately, few studies focused on treatment recurrent LGESS. Our study aimed to investigate prognostic factors and value surgery
Objective:To investigate the clinical features, diagnosis, treatment and prognosis of myoepithelial carcinoma head neck. Method:The data 59 patients with neck admitted from January 2012 to October 2018 were analyzed retrospectively. The was SPSS 21.0 statistical software. Result:The follow-up period 6 131 months. mean time 36 One patient（1.7%） lost follow-up, 17 patients（28.8%） had postoperative local recurrence, 8 patients（13.6%） distant metastasis, 5 patients（8.5%） cervical lymph node...
Abstract Background Perianal fistulas occur in ~30-40% of Crohn’s disease (CD) patients associated with high morbidity and an impaired quality life. The management perianal fistulizing CD is a major clinical challenge, where its underlying etiology remains poorly understood. Methods We recruited 1) (PCD; n = 12); 2) without involvement (NPCD; 10); 3) idiopathic (IPF; 21). Biopsies were taken from the fistula tracts, external opening fistulas, rectal mucosa during examination under anesthesia...